Literature DB >> 17363727

CD4 engagement by CD1d potentiates activation of CD4+ invariant NKT cells.

Aurelie Thedrez1, Claudia de Lalla, Sophie Allain, Luca Zaccagnino, Stephane Sidobre, Claudio Garavaglia, Giovanna Borsellino, Paolo Dellabona, Marc Bonneville, Emmanuel Scotet, Giulia Casorati.   

Abstract

The CD4 coreceptor is crucial in the activation of major histocompatibility complex (MHC) class II restricted CD4 (+) T lymphocytes by binding the same MHC class as the T-cell receptor (TCR) and by potentiating TCR-dependent signaling. CD4 is also expressed by invariant natural killer T cells (iNKT), which recognize natural and synthetic lipid antigens, such as alpha-galactosyl ceramide (alpha-GalCer), in association with the MHC class I-like CD1d molecule. Human iNKT cells can be divided into 2 major subsets depending on CD4 expression: CD4 (+) iNKT preferentially produce T-helper (Th)0/Th2 cytokines, whereas CD4(-) iNKT cells produce Th1 cytokines after antigenic activation. Cytokines produced by iNKT may have immunomodulatory roles in various physiopathologic contexts, but their mode of regulation by iNKT cells remains ill-defined. Using blocking reagents neutralizing CD4 binding, experimental systems where MHC class II molecules are absent and recombinant alpha-GalCer/CD1d complexes, we show that CD4 potentiates human iNKT cell activation by engaging CD1d molecules. These results indicate that the CD4 coreceptors may contribute to the fine tuning of iNKT cells reactivity.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17363727     DOI: 10.1182/blood-2007-01-066217

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  26 in total

Review 1.  Turned on by danger: activation of CD1d-restricted invariant natural killer T cells.

Authors:  Victoria Lawson
Journal:  Immunology       Date:  2012-09       Impact factor: 7.397

Review 2.  CD1d-restricted iNKT cells, the 'Swiss-Army knife' of the immune system.

Authors:  Jennifer L Matsuda; Thierry Mallevaey; James Scott-Browne; Laurent Gapin
Journal:  Curr Opin Immunol       Date:  2008-05-22       Impact factor: 7.486

3.  Lower numbers of natural killer T cells in HIV-1 and Mycobacterium leprae co-infected patients.

Authors:  Karina I Carvalho; Fernanda R Bruno; Jennifer E Snyder-Cappione; Solange M Maeda; Jane Tomimori; Marilia B Xavier; Patrick A Haslett; Douglas F Nixon; Esper G Kallas
Journal:  Immunology       Date:  2012-05       Impact factor: 7.397

4.  Co-delivery of the NKT agonist α-galactosylceramide and tumor antigens to cross-priming dendritic cells breaks tolerance to self-antigens and promotes antitumor responses.

Authors:  Reem Ghinnagow; Julie De Meester; Luis Javier Cruz; Caroline Aspord; Stéphanie Corgnac; Elodie Macho-Fernandez; Daphnée Soulard; Josette Fontaine; Laurence Chaperot; Julie Charles; Fabrice Soncin; Fathia Mami-Chouaib; Joel Plumas; Christelle Faveeuw; François Trottein
Journal:  Oncoimmunology       Date:  2017-08-18       Impact factor: 8.110

5.  MHC class II-expressing thymocytes suppress invariant NKT cell development.

Authors:  Wei Li; M Hanief Sofi; Datsen G Wei; Wenjun Du; Jacquelyn Gervay-Hague; Gourapura J Renukaradhya; Randy R Brutkiewicz; Cheong-Hee Chang
Journal:  Immunol Cell Biol       Date:  2008-11-04       Impact factor: 5.126

Review 6.  Glycolipid ligands of invariant natural killer T cells as vaccine adjuvants.

Authors:  Sungjune Kim; Saif Lalani; Vrajesh V Parekh; Lan Wu; Luc Van Kaer
Journal:  Expert Rev Vaccines       Date:  2008-12       Impact factor: 5.217

Review 7.  Inflammatory targets of therapy in sickle cell disease.

Authors:  Amma Owusu-Ansah; Chibueze A Ihunnah; Aisha L Walker; Solomon F Ofori-Acquah
Journal:  Transl Res       Date:  2015-07-11       Impact factor: 7.012

8.  Invariant TCR rather than CD1d shapes the preferential activities of C-glycoside analogues against human versus murine invariant NKT cells.

Authors:  Xiangming Li; Takayuki Shiratsuchi; Guangwu Chen; Paolo Dellabona; Giulia Casorati; Richard W Franck; Moriya Tsuji
Journal:  J Immunol       Date:  2009-09-04       Impact factor: 5.422

9.  CD4 ligation on human blood monocytes triggers macrophage differentiation and enhances HIV infection.

Authors:  Anjie Zhen; Stephan R Krutzik; Bernard R Levin; Saro Kasparian; Jerome A Zack; Scott G Kitchen
Journal:  J Virol       Date:  2014-06-18       Impact factor: 5.103

10.  ICOS/ICOSL interaction is required for CD4+ invariant NKT cell function and homeostatic survival.

Authors:  Omid Akbari; Philippe Stock; Everett H Meyer; Gordon J Freeman; Arlene H Sharpe; Dale T Umetsu; Rosemarie H DeKruyff
Journal:  J Immunol       Date:  2008-04-15       Impact factor: 5.422

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.